{"name":"Beijing QL Biopharmaceutical Co.,Ltd","slug":"beijing-ql-biopharmaceutical-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Zovaglutide","genericName":"Zovaglutide","slug":"zovaglutide","indication":"Other","status":"phase_3"}]}],"pipeline":[{"name":"Zovaglutide","genericName":"Zovaglutide","slug":"zovaglutide","phase":"phase_3","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxNaVN4WndzSzlxNktGRmpncllBMGdaWml1cnlwZ19CTkd5dVJRWmtjcmlSbGI2NGF0T2tXOFBDVERRUXQ0NkktdF8yX2JDQWl0b19lRjBrN2RBYnBnSmxpTk9DQ0ZSb0J3UkVQRkJnSXFvMnVBR3lIak4yZUJNemV1akMxOXlrNUF5dVN1LVJZdUdpOVJTTEdr?oc=5","date":"2025-09-19","type":"trial","source":"BioWorld News","summary":"QL Biopharm’s monthly GLP-1 meets phase II endpoints - BioWorld News","headline":"QL Biopharm’s monthly GLP-1 meets phase II endpoints","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxOQXp5X0diV3VyOXdQUktubHZTTHhpWjFHMTUwZU5oSG1ldDNrX2JVQWxycTJkQ0JKZVVvQTZoaXpKRXJXX3FUdzd0eWNSSkZXd2FJNDRwUXE3SzFrV0MwZ3R5NXo0MVh6LUszR3g4NUtMSjFqdzJnVVluRVFfM0ZsTmlMLXczZExzdWpxRV9wR2VfNVZBUE9DamoyVUdBNHNHLUFIRXM5eFVoLXlnMG5aaW4yRQ?oc=5","date":"2025-09-18","type":"trial","source":"Fierce Biotech","summary":"QL Biopharm links once-monthly GLP-1 to incumbent-rivaling weight loss in phase 2 - Fierce Biotech","headline":"QL Biopharm links once-monthly GLP-1 to incumbent-rivaling weight loss in phase 2","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxQck4zeTFlZkotWmRwTU9SNHJfRHpoUVZRc0RSS0wxZ1RhWWNGNHlLaHU4eWUtdklEc1lBbUZmdzVfVXpMN3NmLXlRZHEyazJnQWFjQllLbGhzanQ2c1lEdW1ERnUycFo0NHFGc3gxakcwYjJ3SC1jeWpNS3dzQWRvLXR5NXoxdkpfS1l0dzlLZWNrcWx6TVFFTVdfV2I4Zmg2ai1teTFIMTA?oc=5","date":"2024-09-18","type":"pipeline","source":"Citeline News & Insights","summary":"QL Biopharm Fires China’s First Shot At Monthly GLP-1 Obesity Drug - Citeline News & Insights","headline":"QL Biopharm Fires China’s First Shot At Monthly GLP-1 Obesity Drug - Citeline News & Insights","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_3":1},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}